Dr Sandeep Reddy

Oncology

As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.

News

The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.